When COVID-19 vaccines first became available to the general public in 2021, women were concerned over whether it was safe to get vaccinated during pregnancy. The answer (from medical studies) is yes, the vaccines are safe and beneficial for both the mother and baby. This is great news!
Also, a recent study found that when women get a mRNA vaccine (either Pfizer or Moderna) during pregnancy, they pass high levels of antibodies to their babies. This means 100% of the babies had protective antibodies to COVID-19 when they were born. The New York University researchers found the highest level of antibodies in the infants when the mothers received the vaccine in the second half of pregnancy.
Current CDC (Centers for Disease Control and Prevention) guidelines recommend that pregnant and breastfeeding women get the COVID-19 vaccine. This is because getting COVID-19 during pregnancy can result in more severe disease, higher risk of preterm birth and pregnancy outcomes.
BOTTOM LINE: Getting the COVID-19 vaccine during pregnancy protects both the mother and baby. (By the way, studies also find that nursing transfers antibodies to the baby in the breast milk, but it is still unclear if the levels are high enough to fully protect the baby from COVID-19).
From Science Daily: Pregnant women who receive COVID-19 vaccination pass protection from the virus to their newborns
Women who receive the mRNA COVID-19 vaccine during pregnancy pass high levels of antibodies to their babies, a new study finds.
The effectiveness of the Pfizer-BioNTech and Moderna mRNA COVID-19 vaccines, the researchers say, lies in their ability to trigger the production of the right antibodies, blood proteins capable of protecting individuals from infection. Whether this protection could pass from mothers to their infants before birth had remained a question.
Published online September 22 in the American Journal of Obstetrics & Gynecology -- Maternal-Fetal Medicine, the new study of 36 newborns whose mothers received either the Pfizer-BioNTech or Moderna COVID-19 vaccine during pregnancy found that 100 percent of the infants had protective antibodies at birth.
Antibodies can either be produced as part of the natural response to infection or triggered by vaccines. With that in mind, the research team was able to tell apart antibodies in the neonatal blood that were created in response to natural infection from those made in response to the vaccines. The result is relevant because natural antibody responses against the SARS-CoV-2 virus are not sufficiently protective for many people. Recent data from the Centers for Disease Control and Prevention (CDC) suggests that just 23 percent of pregnant women have been vaccinated, despite growing evidence of prenatal vaccine safety.
Led by researchers at NYU Grossman School of Medicine, the study authors observed the highest levels of antibodies in cord blood of mothers who were fully vaccinated during the second half of their pregnancies. This insight provides evidence of transferred immunity to neonates, which correlates to protection against infection for infants during the first months of life.
"Studies continue to reinforce the importance of vaccines during pregnancy and their power to protect two lives at once by preventing severe illness in both mothers and babies," says Ashley S. Roman, MD, director of the Division of Maternal-Fetal Medicine and the Silverman Professor of Obstetrics and Gynecology in the Department of Obstetrics and Gynecology at NYU Langone Health, and one of the study's principal investigators. "If babies could be born with antibodies, it could protect them in the first several months of their lives, when they are most vulnerable."
As the COVID-19 vaccines received authorization from the U.S. Food and Drug Administration, the CDC consistently asserted that they should not be withheld from people who are pregnant and want the vaccine. Dr. Roman and colleagues confirm the strong evidence that the mRNA vaccines are safe during pregnancy in a study published August 16 in the American Journal of Obstetrics & Gynecology -- Maternal-Fetal Medicine, titled "COVID-19 Vaccination in Pregnancy: Early Experience from a Single Institution." The study found no increased risks during pregnancy, birth complications, or identifiable risks to the fetus among those who received the vaccine.